LENSAR, Inc. (LNSR)
NASDAQ: LNSR · IEX Real-Time Price · USD
4.920
+0.020 (0.41%)
At close: Jul 19, 2024, 4:30 PM
5.06
+0.14 (2.85%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
LENSAR Employees
LENSAR had 130 employees as of December 31, 2023. The number of employees increased by 20 or 18.18% compared to the previous year.
Employees
130
Change (1Y)
20
Growth (1Y)
18.18%
Revenue / Employee
$342,308
Profits / Employee
-$94,377
Market Cap
56.07M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 130 | 20 | 18.18% |
| Dec 31, 2022 | 110 | 0 | - |
| Dec 31, 2021 | 110 | 10 | 10.00% |
| Dec 31, 2020 | 100 | 25 | 33.33% |
| Dec 31, 2019 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Allurion Technologies | 504 |
| Neuronetics | 203 |
| Cytosorbents | 186 |
| Adlai Nortye | 127 |
| CollPlant Biotechnologies | 75 |
| Passage Bio | 58 |
| Rallybio | 43 |
| OKYO Pharma | 8 |
LNSR News
- 19 days ago - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference - Business Wire
- 2 months ago - LENSAR Reports First Quarter 2024 Results and Provides Business Update - Business Wire
- 2 months ago - LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 - Business Wire
- 5 months ago - LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update - Business Wire
- 5 months ago - LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024 - Business Wire
- 9 months ago - LENSAR Reports Third Quarter 2023 Results and Provides Business Update - Business Wire
- 9 months ago - LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 - Business Wire